Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-26

Clinical Trial Update: The Effect of Lipitor on Aortic Stenosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating atorvastatin (Lipitor) for progression of aortic valve stenosis was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipitor (atorvastatin)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Aortic Valve Stenosis | Phase 4 | Status: TERMINATED | Results posted: 2017-07-26